Waters Purification Solutions - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Waters Purification Solutions


Waters announces the Prep 150 LC System, a new fit-for-purpose preparative chromatography system designed to isolate target compounds from crude mixtures synthesized in the laboratory or extracted from natural sources during initial purification processes.

"With this system we are responding to requests from scientists for a robust, reliable and dedicated personal chromatography system that can manage the occasional or everyday purification needs of scientists at the bench," said Wendy Harrop, Product Manager, Waters Division. "The introduction of this system demonstrates Waters commitment to serve the needs of scientists not only for analytical-scale LC but for preparative-scale purification as well."

Based on innovative high performance liquid chromatography (HPLC) hardware and software, the Waters Prep 150 LC System features ChromScope™ Software intended for scientists and technicians of all skill levels - from novice to expert - with minimal training. This dedicated HPLC system enables chemists to purify and capture quantities of specific molecular entities as part of their research into new drugs, natural products, and specialty chemicals.

The Waters Prep 150 LC System operates at flow rate ranges of up to 150 mL/min. and features options for detection, sample injection, and solvent delivery systems in order to better suit specific application needs. The Prep 150 LC is supported with a full complement of scalable Waters OBD™ preparative 10 to 50 mm (I.D.) Columns featuring 5 to 10 micron chemistries.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
20%
Attracting a skilled workforce
28%
Obtaining/maintaining adequate financing
12%
Regulatory compliance
40%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here